Table of Contents

<< Previous Issue

Feb 2022 (Vol: 2022, Issue: 2)

Next Issue >>

Download pdf of entire issue

Section: Mergers & Acquisitions
UCB Acquires Zogenix to Bolster its Epilepsy Portfolio Published: 1 Feb-2022
By: Ashish Tripathi
Abstract Fulltext:
Equillium Acquires Bioniz Therapeutics to Strengthen Immunology Portfolio Published: 23 Feb-2022
By: Ayush Saxena & Lucy Haggerty
Abstract Fulltext:
Section: Research & Development
Biogen Bets US$30 M on Genentech’s Lymphoma Bispecific Antibody Published: 5 Feb-2022
By: Lucy Haggerty
Abstract Fulltext:
Janssen Bets US$1.4 B on Mersana’s ADC Platform Published: 18 Feb-2022
By: Ashish Tripathi
Abstract Fulltext:
Amgen Delves into Protein Degrader Therapies with Plexium Collaboration Published: 18 Feb-2022
By: Sasha Yachu
Abstract Fulltext:
Intellia and ONK Collaborate on CRISPR-Edited Cancer Cell Therapies Published: 18 Feb-2022
By: Lucy Haggerty
Abstract Fulltext:
Curve Therapeutics Collaborates with Merck & Co. on Next Generation Drug Discovery Platform Published: 25 Feb-2022
By: Ayush Saxena & Lucy Haggerty
Abstract Fulltext:

Login

Login

Username:

Password:

Keep me logged in

Login Problems? Subscribe

IQVIA™ Pharma Deals: PharmaDeals Review: Table of Contents